Position in ZTS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$25,129,791
+$12,861,461 QoQ
Shares Held
212,586
+118.0% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Gotham Asset Management, LLC holds $204,070,964 across 22 Drug Manufacturers - Specialty & Generic names. ZTS ranks #4 (12.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
4,500,352 | $60,799,755 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
80,387 | $47,667,883 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
360,136 | $47,444,316 | |
| 4 | ZTS |
Zoetis Inc.
This page
|
212,586 | $25,129,791 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
331,032 | $7,921,595 | |
| 6 | BCRX |
Biocryst Pharmaceuticals Inc
|
312,961 | $2,979,388 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
24,095 | $1,852,905 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
55,614 | $1,839,154 |
All Filings in ZTS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $25,129,791 | 212,586 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $12,268,330 | 97,507 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $10,944,882 | 74,801 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $8,768,600 | 56,227 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,952,503 | 17,932 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,299,040 | 7,973 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $775,853 | 3,971 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $441,201 | 2,545 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,133,707 | 6,700 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $397,700 | 2,015 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $308,466 | 1,773 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,055,842 | 11,938 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,430,052 | 8,592 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,888,207 | 19,708 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,974,549 | 20,059 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,864,031 | 16,662 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,065,434 | 21,557 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $791,877 | 3,245 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,156,491 | 5,957 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,052,009 | 11,011 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,675,898 | 23,342 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $4,246,399 | 25,658 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,942,759 | 17,795 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||